Serum transferrin receptors in rheumatoid arthritis.
Journal: 1994/December - Annals of the Rheumatic Diseases
ISSN: 0003-4967
PUBMED: 7979586
Abstract:
OBJECTIVE
Serum transferrin receptors (sTfR) were determined in patients affected by rheumatoid arthritis (RA) to verify a possible relationship with the degree of anaemia and with the severity of the inflammatory disease.
METHODS
sTfR, IL1-b, TNF-a and common parameters of iron metabolism were studied in 72 patients with active RA. Anaemia (Hb < 12 g/dl) was present in 51 patients. Twenty normal healthy subjects and 40 iron-deficient anaemic patients without chronic inflammatory, infective or malignant diseases were studied as controls.
RESULTS
In patients with RA sTfR levels were significantly higher than in the normal group but lower than in iron-deficient anaemic patients and correlated positively with ESR and IL1-b and negatively with Hb. Anaemic patients with RA were divided into two groups. Group A (56%) showed a possible iron deficiency (TSI < 16 and ferritin < 50 ng/ml); group B did not show iron deficiency (TSI>> 16 and ferritin>> 50 ng/ml). No significant difference in sTfR was observed in the two groups.
CONCLUSIONS
sTfR appear to be elevated and related to the degree of anaemia and to the inflammatory process in RA. Reduced sTfR levels in patients with RA compared with patients with iron-deficiency anaemia may indicate a reduced erythropoietic activity in RA.
Relations:
Content
Citations
(4)
References
(12)
Diseases
(2)
Chemicals
(4)
Organisms
(1)
Affiliates
(1)
Similar articles
Articles by the same authors
Discussion board
Ann Rheum Dis 53(10): 699-701

Serum transferrin receptors in rheumatoid arthritis.

Abstract

OBJECTIVE--Serum transferrin receptors (sTfR) were determined in patients affected by rheumatoid arthritis (RA) to verify a possible relationship with the degree of anaemia and with the severity of the inflammatory disease. METHODS--sTfR, IL1-b, TNF-a and common parameters of iron metabolism were studied in 72 patients with active RA. Anaemia (Hb < 12 g/dl) was present in 51 patients. Twenty normal healthy subjects and 40 iron-deficient anaemic patients without chronic inflammatory, infective or malignant diseases were studied as controls. RESULTS--In patients with RA sTfR levels were significantly higher than in the normal group but lower than in iron-deficient anaemic patients and correlated positively with ESR and IL1-b and negatively with Hb. Anaemic patients with RA were divided into two groups. Group A (56%) showed a possible iron deficiency (TSI < 16 and ferritin < 50 ng/ml); group B did not show iron deficiency (TSI > 16 and ferritin > 50 ng/ml). No significant difference in sTfR was observed in the two groups. CONCLUSION--sTfR appear to be elevated and related to the degree of anaemia and to the inflammatory process in RA. Reduced sTfR levels in patients with RA compared with patients with iron-deficiency anaemia may indicate a reduced erythropoietic activity in RA.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (548K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Baer AN, Dessypris EN, Krantz SB. The pathogenesis of anemia in rheumatoid arthritis: a clinical and laboratory analysis. Semin Arthritis Rheum. 1990 Feb;19(4):209–223. [PubMed] [Google Scholar]
  • Huebers HA, Beguin Y, Pootrakul P, Einspahr D, Finch CA. Intact transferrin receptors in human plasma and their relation to erythropoiesis. Blood. 1990 Jan 1;75(1):102–107. [PubMed] [Google Scholar]
  • Cazzola M, Beguin Y. New tools for clinical evaluation of erythron function in man. Br J Haematol. 1992 Mar;80(3):278–284. [PubMed] [Google Scholar]
  • Maury CP, Andersson LC, Teppo AM, Partanen S, Juvonen E. Mechanism of anaemia in rheumatoid arthritis: demonstration of raised interleukin 1 beta concentrations in anaemic patients and of interleukin 1 mediated suppression of normal erythropoiesis and proliferation of human erythroleukaemia (HEL) cells in vitro. Ann Rheum Dis. 1988 Dec;47(12):972–978.[PMC free article] [PubMed] [Google Scholar]
  • Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988 Mar;31(3):315–324. [PubMed] [Google Scholar]
  • Huebers HA, Finch CA. The physiology of transferrin and transferrin receptors. Physiol Rev. 1987 Apr;67(2):520–582. [PubMed] [Google Scholar]
  • Intragumtornchai T, Huebers HA, Eng M, Finch CA. In vivo transferrin-iron receptor relationships in erythron of rats. Am J Physiol. 1988 Aug;255(2 Pt 2):R326–R331. [PubMed] [Google Scholar]
  • Rao KK, Shapiro D, Mattia E, Bridges K, Klausner R. Effects of alterations in cellular iron on biosynthesis of the transferrin receptor in K562 cells. Mol Cell Biol. 1985 Apr;5(4):595–600.[PMC free article] [PubMed] [Google Scholar]
  • Cazzola M, Bergamaschi G, Dezza L, Arosio P. Manipulations of cellular iron metabolism for modulating normal and malignant cell proliferation: achievements and prospects. Blood. 1990 May 15;75(10):1903–1919. [PubMed] [Google Scholar]
  • Neckers LM. Regulation of transferrin receptor expression and control of cell growth. Pathobiology. 1991;59(1):11–18. [PubMed] [Google Scholar]
  • Reichard P, Ehrenberg A. Ribonucleotide reductase--a radical enzyme. Science. 1983 Aug 5;221(4610):514–519. [PubMed] [Google Scholar]
  • Duff GW. Cytokines and anti-cytokines. Br J Rheumatol. 1993 Mar;32 (Suppl 1):15–20. [PubMed] [Google Scholar]
Università Cattolica del Sacro Cuore, Rome, Italy.
Università Cattolica del Sacro Cuore, Rome, Italy.
Abstract
OBJECTIVE--Serum transferrin receptors (sTfR) were determined in patients affected by rheumatoid arthritis (RA) to verify a possible relationship with the degree of anaemia and with the severity of the inflammatory disease. METHODS--sTfR, IL1-b, TNF-a and common parameters of iron metabolism were studied in 72 patients with active RA. Anaemia (Hb < 12 g/dl) was present in 51 patients. Twenty normal healthy subjects and 40 iron-deficient anaemic patients without chronic inflammatory, infective or malignant diseases were studied as controls. RESULTS--In patients with RA sTfR levels were significantly higher than in the normal group but lower than in iron-deficient anaemic patients and correlated positively with ESR and IL1-b and negatively with Hb. Anaemic patients with RA were divided into two groups. Group A (56%) showed a possible iron deficiency (TSI < 16 and ferritin < 50 ng/ml); group B did not show iron deficiency (TSI > 16 and ferritin > 50 ng/ml). No significant difference in sTfR was observed in the two groups. CONCLUSION--sTfR appear to be elevated and related to the degree of anaemia and to the inflammatory process in RA. Reduced sTfR levels in patients with RA compared with patients with iron-deficiency anaemia may indicate a reduced erythropoietic activity in RA.
Collaboration tool especially designed for Life Science professionals.Drag-and-drop any entity to your messages.